ASTRAZENECA PLC (AZN)
Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17
Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17
Clinical trial NCT07571200 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-14
Clinical trial NCT04205812 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-28 → 2026-05-28
Clinical trial NCT05272150: enrollment: 213 → 211 participants.
Clinical trial NCT06952010 updates: 1. enrollment: 75 → 303 participants 2. allocation: NA → NON_RANDOMIZED
Clinical trial NCT06892548 updates: 1. completion date: 2031-06-01 → 2032-05-01 2. primary completion date: 2027-08-01 → 2028-09-01
Clinical trial NCT06768489: completion date: 2028-11-23 → 2029-01-02.
Clinical trial NCT05280548: primary completion date: 2026-05-15 → 2026-05-22.
Clinical trial NCT05346354 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-04-02 → 2029-03-30 3. primary completion date: 2026-03-31 → 2026-06-22 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07504601: start date: 2026-06-28 → 2026-06-29.